Quantum Genomics Société Anonyme (ALQGC.PA)
EUR 0.07
(0.0%)
EUR 0.07
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.96 Million EUR | -18.87% |
| 2022 | 2.41 Million EUR | -16.16% |
| 2021 | 2.88 Million EUR | 513.19% |
| 2020 | 470 Thousand EUR | -4.08% |
| 2019 | 490 Thousand EUR | 21524.01% |
| 2018 | 2266.00 EUR | 105.07% |
| 2017 | 1105.00 EUR | 8.02% |
| 2016 | 1023.00 EUR | 58.11% |
| 2015 | 647.00 EUR | -99.78% |
| 2014 | 300.55 Thousand EUR | -4.62% |
| 2013 | 315.11 Thousand EUR | 926714.71% |
| 2012 | 34.00 EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.69 Million EUR | 0.0% |
| 2023 FY | 1.96 Million EUR | -18.87% |
| 2023 Q4 | 1.96 Million EUR | 0.0% |
| 2023 Q2 | 2.9 Million EUR | 0.0% |
| 2022 Q2 | 2.81 Million EUR | 0.0% |
| 2022 FY | 2.41 Million EUR | -16.16% |
| 2022 Q4 | 2.41 Million EUR | 0.0% |
| 2021 FY | 2.88 Million EUR | 513.19% |
| 2021 Q2 | 1.5 Million EUR | 0.0% |
| 2021 Q4 | 2.88 Million EUR | 0.0% |
| 2020 Q4 | 470 Thousand EUR | 0.0% |
| 2020 FY | 470 Thousand EUR | -4.08% |
| 2020 Q2 | 2.35 Million EUR | 0.0% |
| 2019 FY | 490 Thousand EUR | 21524.01% |
| 2019 Q2 | 1132.00 EUR | 0.0% |
| 2019 Q4 | 1382.00 EUR | 0.0% |
| 2018 Q4 | 2266.00 EUR | 0.0% |
| 2018 FY | 2266.00 EUR | 105.07% |
| 2018 Q2 | 1248.00 EUR | 0.0% |
| 2017 Q2 | 927.00 EUR | 0.0% |
| 2017 FY | 1105.00 EUR | 8.02% |
| 2017 Q4 | 1105.00 EUR | 0.0% |
| 2016 Q2 | 824.00 EUR | 0.0% |
| 2016 FY | 1023.00 EUR | 58.11% |
| 2016 Q4 | 1023.00 EUR | 0.0% |
| 2015 Q4 | 647.00 EUR | 0.0% |
| 2015 Q2 | 819.00 EUR | 0.0% |
| 2015 FY | 647.00 EUR | -99.78% |
| 2014 Q4 | 300.55 Thousand EUR | 0.0% |
| 2014 Q2 | 5493.00 EUR | 0.0% |
| 2014 FY | 300.55 Thousand EUR | -4.62% |
| 2013 FY | 315.11 Thousand EUR | 926714.71% |
| 2013 Q4 | 315.11 Thousand EUR | 0.0% |
| 2012 FY | 34.00 EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ABIONYX Pharma SA | 1.1 Million EUR | -78.05% |
| ABIVAX Société Anonyme | 44.69 Million EUR | 95.614% |
| Adocia SA | 4.54 Million EUR | 56.821% |
| Aelis Farma SA | 2.04 Million EUR | 4.281% |
| Biophytis S.A. | 3.11 Million EUR | 36.987% |
| Advicenne S.A. | 15.89 Million EUR | 87.668% |
| genOway Société anonyme | 5.51 Million EUR | 64.482% |
| IntegraGen SA | 642.28 Thousand EUR | -205.214% |
| Medesis Pharma S.A. | 1.2 Million EUR | -63.361% |
| Neovacs S.A. | 650 Thousand EUR | -201.589% |
| NFL Biosciences SA | 39.2 Thousand EUR | -4900.457% |
| Plant Advanced Technologies SA | 4.35 Million EUR | 55.002% |
| Sensorion SA | 1.24 Million EUR | -57.975% |
| Theranexus Société Anonyme | 2.46 Million EUR | 20.335% |
| TME Pharma N.V. | - EUR | -Infinity% |
| Valbiotis SA | 3.89 Million EUR | 49.709% |
| TheraVet SA | 1 Million EUR | -95.916% |
| Valerio Therapeutics Société anonyme | 6.9 Million EUR | 71.614% |
| argenx SE | 15.35 Million EUR | 87.232% |
| BioSenic S.A. | 15.57 Million EUR | 87.412% |
| Celyad Oncology SA | 902 Thousand EUR | -117.331% |
| DBV Technologies S.A. | 4.52 Million USD | 56.687% |
| Galapagos NV | 4.94 Million EUR | 60.349% |
| Genfit S.A. | 62.25 Million EUR | 96.851% |
| GeNeuro SA | 6.49 Million EUR | 69.805% |
| Hyloris Pharmaceuticals SA | 344 Thousand EUR | -469.863% |
| Innate Pharma S.A. | 30.6 Million EUR | 93.595% |
| Inventiva S.A. | 25.61 Million EUR | 92.347% |
| MaaT Pharma SA | 5.42 Million EUR | 63.865% |
| MedinCell S.A. | 52.8 Million EUR | 96.287% |
| Nanobiotix S.A. | 41.66 Million EUR | 95.294% |
| Onward Medical N.V. | 16.3 Million EUR | 87.978% |
| Oryzon Genomics S.A. | 3.45 Million EUR | 43.189% |
| OSE Immunotherapeutics SA | 35.5 Million EUR | 94.479% |
| Oxurion NV | 117 Thousand EUR | -1575.495% |
| Pharming Group N.V. | 123.65 Million EUR | 98.415% |
| Poxel S.A. | 40.14 Million EUR | 95.117% |
| GenSight Biologics S.A. | 1.04 Million EUR | -87.054% |
| Transgene SA | 17 Thousand EUR | -11431.347% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 2.87 Billion EUR | 99.932% |
| Valneva SE | 132.76 Million EUR | 98.523% |
| Vivoryon Therapeutics N.V. | - EUR | -Infinity% |